Sun Pharma appoints former PwC India COO Satyavati Berera as independent director
Board approves five-year appointment, subject to shareholder nod through postal ballot
Board approves five-year appointment, subject to shareholder nod through postal ballot
Wholly owned subsidiary KIMS Swastha signs hospital management and sub-lease deal for 210-bed facility, with option to acquire majority stake later
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
The company said the increase—up to 20%—takes effect immediately, or as current contracts allow
The SirPAD trial marks a significant milestone in vascular intervention, positioning MagicTouch PTA as a promising future alternative for PAD treatment
Low-dose radiotherapy offers immediate pain relief, quicker recovery, and better movement through a non-invasive procedure
Empowering 15 Women in STEM (Life Sciences) with scholarship, internship and mentorship
Ac-225, an alpha-emitting radionuclide, can be paired with molecules designed to selectively target cancer cells.
Enthral.ai’s platform integrates AI-driven capabilities with compliance-first architecture, enabling automated training workflows
The center brings together hands on technology demonstrations, application expertise, and commercial operations
Subscribe To Our Newsletter & Stay Updated